Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

2.

Hepatotoxicity by Drugs: The Most Common Implicated Agents.

Björnsson ES.

Int J Mol Sci. 2016 Feb 6;17(2):224. doi: 10.3390/ijms17020224. Review.

3.

Drug-induced liver injury: an overview over the most critical compounds.

Björnsson ES.

Arch Toxicol. 2015 Mar;89(3):327-34. doi: 10.1007/s00204-015-1456-2. Epub 2015 Jan 25. Review.

PMID:
25618544
4.

The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond.

Lewis JH.

Clin Gastroenterol Hepatol. 2015 Nov;13(12):2173-89.e8. doi: 10.1016/j.cgh.2015.06.017. Epub 2015 Jun 23. Review.

PMID:
26116527
5.

Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.

Fontana RJ.

Gastroenterology. 2014 Apr;146(4):914-28. doi: 10.1053/j.gastro.2013.12.032. Epub 2013 Dec 31. Review.

6.

Drug-induced liver injury: Do we know everything?

Alempijevic T, Zec S, Milosavljevic T.

World J Hepatol. 2017 Apr 8;9(10):491-502. doi: 10.4254/wjh.v9.i10.491. Review.

7.

Review article: Herbal hepatotoxicity--an update on traditional Chinese medicine preparations.

Teschke R, Wolff A, Frenzel C, Schulze J.

Aliment Pharmacol Ther. 2014 Jul;40(1):32-50. doi: 10.1111/apt.12798. Epub 2014 May 20. Review.

8.

LiverTox: An online information resource and a site for case report submission on drug-induced liver injury.

Serrano J.

Clin Liver Dis (Hoboken). 2014 Jul 25;4(1):22-25. doi: 10.1002/cld.388. eCollection 2014 Jul. Review. No abstract available.

9.

Herbal hepatotoxicity: suspected cases assessed for alternative causes.

Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C.

Eur J Gastroenterol Hepatol. 2013 Sep;25(9):1093-8. doi: 10.1097/MEG.0b013e3283603e89. Review.

PMID:
23510966
10.

Drug-induced liver injury: what was new in 2008?

Liss G, Lewis JH.

Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):843-60. doi: 10.1517/17425250903018904. Review.

PMID:
19505188
11.

Review article: herbal and dietary supplement hepatotoxicity.

Bunchorntavakul C, Reddy KR.

Aliment Pharmacol Ther. 2013 Jan;37(1):3-17. doi: 10.1111/apt.12109. Epub 2012 Nov 5. Review.

12.

Herbal hepatotoxicity: a tabular compilation of reported cases.

Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A.

Liver Int. 2012 Nov;32(10):1543-56. doi: 10.1111/j.1478-3231.2012.02864.x. Epub 2012 Aug 28. Review.

PMID:
22928722
13.

Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation.

Frenzel C, Teschke R.

Int J Mol Sci. 2016 Apr 27;17(5). pii: E588. doi: 10.3390/ijms17050588. Review.

14.

Hepatotoxicity of targeted therapy for cancer.

Lee KW, Chan SL.

Expert Opin Drug Metab Toxicol. 2016 Jul;12(7):789-802. doi: 10.1080/17425255.2016.1190831. Epub 2016 Jun 6. Review.

PMID:
27187715
15.

Liver injury from herbal and dietary supplements.

Navarro VJ, Khan I, Björnsson E, Seeff LB, Serrano J, Hoofnagle JH.

Hepatology. 2017 Jan;65(1):363-373. doi: 10.1002/hep.28813. Epub 2016 Nov 17. Review.

16.

Adverse Drug Reactions: Type A (Intrinsic) or Type B (Idiosyncratic).

Iasella CJ, Johnson HJ, Dunn MA.

Clin Liver Dis. 2017 Feb;21(1):73-87. doi: 10.1016/j.cld.2016.08.005. Epub 2016 Oct 13. Review.

PMID:
27842776
17.

Trace Elements and Metals.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
2019 Jun 4.

18.

Drug-induced liver injury: present and future.

Suk KT, Kim DJ.

Clin Mol Hepatol. 2012 Sep;18(3):249-57. doi: 10.3350/cmh.2012.18.3.249. Epub 2012 Sep 25. Review.

19.

Herbal medications and other dietary supplements. A clinical review for physicians caring for older people.

Pitkälä KH, Suominen MH, Bell JS, Strandberg TE.

Ann Med. 2016 Dec;48(8):586-602. Epub 2016 Jul 16. Review.

PMID:
27427263
20.

Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States.

Hayashi PH.

Int J Mol Sci. 2016 Feb 4;17(2):201. doi: 10.3390/ijms17020201. Review.

Supplemental Content

Support Center